SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009821
Filing Date
2020-08-07
Accepted
2020-08-07 08:07:00
Documents
57
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20200630x10q.htm   iXBRL 10-Q 1978851
2 EX-10.2 edit-20200630xex10d2.htm EX-10.2 68605
3 EX-10.3 edit-20200630xex10d3.htm EX-10.3 63471
4 EX-31.1 edit-20200630xex31d1.htm EX-31.1 16282
5 EX-31.2 edit-20200630xex31d2.htm EX-31.2 15804
6 EX-32.1 edit-20200630xex32d1.htm EX-32.1 10145
7 GRAPHIC edit-20200630xex10d2002.jpg GRAPHIC 3354
  Complete submission text file 0001558370-20-009821.txt   6103809

Data Files

Seq Description Document Type Size
8 EX-101.SCH edit-20200630.xsd EX-101.SCH 26664
9 EX-101.CAL edit-20200630_cal.xml EX-101.CAL 41690
10 EX-101.DEF edit-20200630_def.xml EX-101.DEF 93517
11 EX-101.LAB edit-20200630_lab.xml EX-101.LAB 323083
12 EX-101.PRE edit-20200630_pre.xml EX-101.PRE 222332
13 EXTRACTED XBRL INSTANCE DOCUMENT edit-20200630x10q_htm.xml XML 1017610
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 201083788
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences